OGG1 and metabolic disease: Interestingly, the genetic polymorphism in OGG1 (Ser[326]Cys) has been associated with T2D risk in MAs26 further suggesting that insufficient response to oxidative DNA damage may be implicated in metabolic disease in the MA population.